Logicbio
1 known investors
LogicBio develops research and therapeutics for rare genetic diseases. The company investigates novel targets, modalities, and technologies to advance treatment options for rare disease patients globally.
1 known investors
LogicBio develops research and therapeutics for rare genetic diseases. The company investigates novel targets, modalities, and technologies to advance treatment options for rare disease patients globally.